Vasohibin-1 suppresses colon cancer.
Jinan, China. In Oncotarget, May 2015
Vasohibin-1 (VASH1) is an endogenous angiogenesis inhibitor.However, the clinical relevance of VASH1 in colon cancer and its regulations on cancer angiogenesis and cancer cell biological characteristics are still unknown.
Emerging roles of immune cells in luteal angiogenesis.
Obihiro, Japan. In Reprod Fertil Dev, 2012
However, the negative feedback regulator vasohibin-1 in the CL prevents excessive tumour-like vasculogenesis, suggesting that CL development has well coordinated time-dependent mechanisms.
Regulation of tumor angiogenesis by EZH2.
Houston, United States. In Cancer Cell, 2010
The increase in endothelial EZH2 is a direct result of VEGF stimulation by a paracrine circuit that promotes angiogenesis by methylating and silencing vasohibin1 (vash1).